2 years ago
ARDX
AnalystsLaura ChicoLaura Chico's Stock Forecasts
AnalystsLaura Chico
Analyst Ranking
Top 7%
#324 out of 5087 analysts
Average Return
+14.33%
Win Rate
47%85 out of 182
Risk vs Reward
Poor
Good
Laura Chico's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Longboard Pharmaceuticals IncLBPH | +658.28% | $5.13 | $38.90 | 2023-10-12 - 2024-10-11 | Buy |
Edgewise Therapeutics IncEWTX | +560.25% | $5.51 | $36.38 | 2023-11-10 - 2024-11-08 | Buy |
Vigil Neuroscience IncVIGL | +290.10% | $2.02 | $7.88 | 2025-03-14 - 2025-05-22 | Buy |
Tourmaline Bio IncTRML | +232.45% | $14.33 | $47.64 | 2025-03-06 - 2025-09-09 | Buy |
Longboard Pharmaceuticals IncLBPH | +200.50% | $19.96 | $59.98 | 2024-03-13 - 2024-11-29 | Buy |
Laura Chico Analyst Color
Get additional color on Laura Chico's coverage of popular stocks
Laura Chico's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Astria Therapeutics IncATXS | 10 | Hold | $13.00 | +2.93% | Downgrades | 18 days ago |
Larimar Therapeutics IncLRMR | 3 | Buy | $11.00 | +182.78% | Maintains | a month ago |
Pepgen IncPEPG | 12 | Buy | $8.00 | +71.67% | Maintains | a month ago |
Dianthus Therapeutics IncDNTH | 9 | Buy | $44.00 | +25.79% | Maintains | 2 months ago |
Tourmaline Bio IncTRML | 3 | Hold | $48.00 | +0.04% | Downgrades | 2 months ago |
Jade Biosciences IncJBIO | 6 | Buy | $18.00 | +83.67% | Maintains | 3 months ago |
Solid Biosciences IncSLDB | 3 | Buy | $14.00 | +159.74% | Maintains | 3 months ago |
Stoke Therapeutics IncSTOK | 7 | Buy | $22.00 | -26.76% | Maintains | 3 months ago |
Xenon Pharmaceuticals IncXENE | 9 | Buy | $43.00 | +2.58% | Maintains | 3 months ago |
Travere Therapeutics IncTVTX | 12 | Buy | $32.00 | -8.99% | Maintains | 3 months ago |
Gossamer Bio IncGOSS | 6 | Buy | $5.00 | +104.08% | Maintains | 3 months ago |
Ardelyx IncARDX | 14 | Buy | $14.00 | +131.02% | Maintains | 3 months ago |
Neurocrine Biosciences IncNBIX | 10 | Buy | $141.00 | -1.54% | Maintains | 3 months ago |
Ultragenyx Pharmaceutical IncRARE | 12 | Hold | $34.00 | -1.73% | Maintains | 4 months ago |
Maze Therapeutics IncMAZE | 1 | Buy | $17.00 | -48.34% | Initiates Coverage On | 4 months ago |
Biocryst Pharmaceuticals IncBCRX | 1 | Buy | $18.00 | +145.90% | Maintains | 4 months ago |
Lennar CorpLEN | 1 | Hold | $130.00 | +5.03% | Reiterates | 4 months ago |
Biogen IncBIIB | 15 | Hold | $121.00 | -21.57% | Reiterates | 5 months ago |
Pharvaris NvPHVS | 7 | Buy | $27.00 | +21.51% | Reiterates | 5 months ago |
Vigil Neuroscience IncVIGL | 11 | Hold | $8.00 | -0.62% | Downgrades | 5 months ago |
Alto Neuroscience IncANRO | 4 | Hold | $4.00 | -71.81% | Reiterates | 6 months ago |
Vera Therapeutics IncVERA | 8 | Hold | $26.00 | -8.64% | Maintains | 6 months ago |
Denali Therapeutics IncDNLI | 8 | Buy | $30.00 | +84.28% | Maintains | 6 months ago |
Praxis Precision Medicines IncPRAX | 7 | Sell | $28.00 | -85.91% | Maintains | 6 months ago |
Edgewise Therapeutics IncEWTX | 10 | Buy | $43.00 | +135.23% | Maintains | 6 months ago |
Ovid Therapeutics IncOVID | 2 | Buy | $3.00 | +115.83% | Maintains | 8 months ago |
Apellis Pharmaceuticals IncAPLS | 13 | Hold | $29.00 | +35.07% | Maintains | 8 months ago |
Sage Therapeutics IncSAGE | 7 | Hold | $6.00 | -30.88% | Reiterates | 9 months ago |
Longboard Pharmaceuticals IncLBPH | 7 | Buy | $44.00 | N/A | Maintains | a year ago |
Voyager Therapeutics IncVYGR | 3 | Hold | $7.00 | N/A | Maintains | a year ago |
Viridian Therapeutics IncVRDN | 7 | Buy | $42.00 | N/A | Reiterates | a year ago |
Rallybio CorpRLYB | 4 | Buy | $11.00 | N/A | Maintains | 2 years ago |
Design Therapeutics IncDSGN | 5 | Hold | $5.00 | N/A | Reiterates | 2 years ago |
Karuna Therapeutics IncKRTX | 4 | Hold | $330.00 | N/A | Downgrades | 2 years ago |
Chinook Therapeutics IncKDNY | 3 | Hold | $42.00 | N/A | Downgrades | 2 years ago |
Impel Pharmaceuticals IncIMPLQ | 2 | Hold | $5.00 | N/A | Downgrades | 3 years ago |
Taysha Gene Therapies IncTSHA | 2 | Buy | $5.00 | N/A | Maintains | 3 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 1 | Hold | $148.50 | N/A | Downgrades | 3 years ago |
Viela Bio IncVIE | 2 | Hold | N/A | N/A | Downgrades | 5 years ago |
Biomarin Pharmaceutical IncBMRN | 3 | Buy | $110.00 | N/A | Reinstates | 7 years ago |
Acer Therapeutics IncACER | 2 | Buy | $40.00 | N/A | Reinstates | 7 years ago |
Paratek Pharmaceuticals IncPRTK | 2 | Buy | N/A | N/A | Downgrades | 8 years ago |
Bioverativ IncBIVV | 1 | Hold | N/A | N/A | Downgrades | 8 years ago |
Corbus Pharmaceuticals Holdings IncCRBP | 1 | Buy | $720.00 | N/A | Initiates Coverage On | 8 years ago |
Cidara Therapeutics IncCDTX | 1 | Strong Buy | $280.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.